Nephros(NEPH)

TOPVIEW |2021.7.8 Bio-market主要涨跌一览

蹊之美股生物医药2021-07-09 20:55

作者：林出
微信公众号：蹊之美股生物医药 / CaesarBiotech
Gainers: 
Aerpio Pharm (ARPO) +63.16%
GBS Inc (GBS) +33.22%
Alterity Therapeutics (ATHE) +27.85%
9 Meters Biopharma (NMTR) +20.39%
F-star Therapeutics (FSTX) +9.13%
Los...查看全文

$Nephros(NEPH)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2019-11-06 AccNo: 0001493152-19-016513 Size: 4 MB 网页链接

$Nephros(NEPH)$ S-3 - Registration statement under Securities Act of 1933 Filed: 2019-11-06 AccNo: 0001493152-19-016515 Size: 1 MB 网页链接

$Nephros(NEPH)$ 424B3 - Prospectus [Rule 424(b)(3)] Filed: 2019-10-16 AccNo: 0001493152-19-015575 Size: 327 KB 网页链接

$Nephros(NEPH)$ 424B3 - Prospectus [Rule 424(b)(3)] Filed: 2019-10-16 AccNo: 0001493152-19-015576 Size: 220 KB 网页链接

$Nephros(NEPH)$ EFFECT - Notice of Effectiveness Filed: 2019-10-15 AccNo: 9999999995-19-002307 Size: 1 KB 网页链接

$Nephros(NEPH)$ EFFECT - Notice of Effectiveness Filed: 2019-10-15 AccNo: 9999999995-19-002309 Size: 1 KB 网页链接

$Nephros(NEPH)$ POS AM - Post-Effective amendments for registration statement Filed: 2019-10-09 AccNo: 0001493152-19-015303 Size: 445 KB 网页链接

$Nephros(NEPH)$ POS AM - Post-Effective amendments for registration statement Filed: 2019-10-09 AccNo: 0001493152-19-015305 Size: 334 KB 网页链接

$Nephros(NEPH)$ 8-K - Current report Filed: 2019-10-07 AccNo: 0001493152-19-015141 Size: 65 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接

$Nephros(NEPH)$ D/A [Amend] - Notice of Exempt Offering of Securities Filed: 2019-09-12 AccNo: 0001437749-19-018307 Size: 12 KB 网页链接